Picking the Best Antibody Therapeutic Candidates to Develop the Most Effective COVID-19 Therapeutic Cocktail
Read More
Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein
Read More
Nature Webinar: Accelerating Drug Discovery at a Pandemic Pace
Read More
Application Note: Monitoring Immune Response to SARS-CoV-2
Read More
The Coronavirus Immunotherapy Consortium (CoVIC) Uses HT-SPR To Identify the Most Potent, Mutation-Resistant Cocktails of Therapeutics Antibodies
Read More
Interview on the Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies
Watch Interview
Bamlanivimab (LY-CoV555) is the First COVID-19 Therapeutic Made Available to the Public by the FDA
Read More
Carterra Supercharges Antibody Discovery Workflows for LakePharma with High-Throughput SPR
Read More
Carterra’s Scientist to Scientist Series: Daniel Bedinger and Tom Yuan from Twist Bioscience
Watch Interview
Carterra Helps Provide Breakthrough Analysis for Understanding the Immunity of COVID-19 Patients by Scientists in Europe
Watch the Webinar
